Prevalence Rate of Thalassemia Carriers among Individuals with Microcytosis or Hypochromia in Portugal
Keywords:Erythrocytes, Erythrocyte Indices, Hematologic Tests, Portugal, Thalassemia/diagnosis, Thalassemia/genetics
Introduction: Microcytosis and hypochromia result from deficient hemoglobin synthesis in red blood cells and are easily detected in a complete blood count test. These conditions are mainly due to iron nutritional deficiency, but may also result from some genetic diseases, such as thalassemia. The aim of this study was to determine the contribution of β- and α-thalassemia to these abnormal hematological phenotypes in a representative sample of adult individuals living in Portugal who participated in the first Portuguese National Health Examination Survey (INSEF).
Material and Methods: Among the 4808 INSEF participants, 204 had microcytosis, hypochromia or both. The corresponding 204 DNAs were screened for changes in the β-globin gene by next-generation sequencing and Sanger sequencing. In addition, α-thalassemia deletions within the α-globin cluster were investigated by Gap-PCR and multiplex ligation-dependent probe amplification.
Results: In this selected subgroup of INSEF participants, 54 had α-thalassemia (26%), predominantly caused by the -α3.7kb deletion, and 22 were β-thalassemia carriers (11%) mainly due to point mutations in the β-globin gene previously known in Portugal.
Conclusion: Thalassemia trait is a frequent cause of microcytosis or hypochromia in Portugal since this genetic condition was found in 37% of the investigated cases.
World Health Organization. Worldwide prevalence of anaemia 1993-2005. 2020. [cited 2023 Jan 25]. Available from: https://www.who.int/publications/i/item/9789241596657.
Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387:907-16.
Fonseca C, Marques F, Robalo Nunes A, Belo A, Brilhante D, Cortez J. Prevalence of anaemia and iron deficiency in Portugal: The EMPIRE Study. Intern Med J. 2016;46:470-8.
Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia. Lancet. 2012;379:373-83.
Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79:704-12.
Modell B, Darlison M, Birgens H, Cario H, Faustino P, Giordano PC, et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest. 2007;67:39-69.
Peres MJ, Romão L, Carreiro H, Picanço I, Batalha L, Magalhães HA, et al. Molecular basis of alpha-thalassemia in Portugal. Hemoglobin. 1995;19:343-52.
Martins MC, Olim G, Melo J, Magalhães HA, Rodrigues MO. Hereditary anaemias in Portugal: epidemiology, public health significance, and control. J Med Genet. 1993;30:235-9.
Inez F, Sequeira M, Santos P, Santos R, Nunes E, Cavaco A, et al. Contribuição do rastreio de portadores para a prevenção da beta-talassémia e da drepanocitose na população portuguesa: um estudo multicêntrico. Arq Inst Nac Saúde. 1993;19:27–31.
Bento C, Relvas L, Vazão H, Campos J, Rebelo U, Ribeiro ML. The use of capillary blood samples in a large scale screening approach for the detection of beta-thalassemia and hemoglobin variants. Haematologica. 2006;91:1565.
Direção-Geral da Saúde. Prevenção das formas graves de hemoglobinopatia: circular normativa nº 18/DSMIA, de 07/09/2004. Lisboa: DGS; 2004.
Nunes B, Barreto M, Gil AP, Kislaya I, Namorado S, Antunes L, et al. The first Portuguese National Health Examination Survey (2015): design, planning and implementation. J Public Health. 2019;41:511-7.
World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011. [cited 2022 Sep 05]. Available from: https://apps.who.int/iris/handle/10665/85839.
Direção-Geral da Saúde. Abordagem, diagnóstico e tratamento da ferropénia no adulto. Norma 030/2013, de 31/12/2013, atualizada em 09/04/2015. Lisboa: DGS; 2015.
Howe KL, Achuthan P, Allen J, Allen J, Alvarez-Jarreta J, Amode MR, et al. Ensembl 2021. Nucleic Acids Res. 2021;49:D884–91.
Dodé C, Krishnamoorthy R, Lamb J, Rochette J. Rapid analysis of -α3.7 thalassaemia and αααanti3.7 triplication by enzymatic amplification analysis. Br J Haematol. 1993;83:105-11.
Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis. 2010;5:13.
Harteveld CL, Voskamp A, Phylipsen M, Akkermans N, den Dunnen JT, White SJ, et al. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing α and β thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J Med Genet. 2005;42:922-31.
Faustino P, Pacheco P, Loureiro P, Nogueira PJ, Lavinha J. The geographic pattern of beta-thalassaemia mutations in the Portuguese population. Br J Haematol. 1999;107:903-4.
Samões C, Kislaya I, Sousa-Uva M, Gaio V, Faustino P, Nunes B. Prevalence of anemia in the Portuguese adult population: results from the first National Health Examination Survey (INSEF 2015). J Public Health. 2022;30:1033-40.
Pearson HA, Ehrenkranz RA, Rinder HM, Riely CA. Hemosiderosis in a normal child secondary to oral iron medication. Pediatrics. 2000;105:429-31.
Galanello R, Cao A. Gene test review. Alpha-thalassemia. Genet Med. 2011;13:83-8.
Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010;12:61-76.
Ropero P, González Fernández FA, Nieto JM, Torres-Jiménez WM, Benavente C. β-Thalassemia intermedia: interaction of α-globin gene triplication with β-thalassemia heterozygous in Spain. Front Med. 2022;9:866396.
Hoffmann JJ, Urrechaga E. Verification of 20 mathematical formulas for discriminating between iron deficiency anemia and thalassemia trait in microcytic anemia. Lab Med. 2020;51:628-34.
Jayabose S, Giamelli J, Levondoglu Tugal O, Sandoval C, Ozkaynak F, Visintainer P. Differentiating iron deficiency anemia from thalassemia minor by using an RDW-based index. J Pediatr Hematol Oncol. 1999;21:314.
Al-Numan AH, Al-Obeidi RA. The value of the red cell distribution width index versus other parameters in the differentiation between iron deficiency anemia and beta thalassemia trait among children in Mosul, Iraq. Expert Rev Hematol. 2021;14:401-6.
Bachir D, Galacteros F. Hemoglobin C disease. 2004. [cited 2022 Sep 12]. Available from: http://www.orpha.net/data/patho/GB/uk-HbC.pdf.
Kountouris P, Lederer CW, Fanis P, Feleki X, Old J, Kleanthous M. IthaGenes: an interactive database for haemoglobin variants and epidemiology. PLoS ONE. 2014;9:e103020.
How to Cite
Copyright (c) 2023 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.